Context Capital Management, LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664WAB1. A total of 19 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
Context Capital Management, LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$9,298
-12.4%
17,851
-16.4%
0.75%
-22.2%
Q2 2023$10,609
+21.1%
21,351
-2.3%
0.96%
+30.3%
Q1 2023$8,764
+31.0%
21,851
+79.6%
0.74%
+50.2%
Q4 2022$6,690
-99.9%
12,164
-17.6%
0.49%
-12.0%
Q3 2022$8,274,000
+1.8%
14,7640.0%0.56%
-4.1%
Q2 2022$8,131,000
-5.3%
14,764
-9.2%
0.58%
+4.1%
Q1 2022$8,586,000
-13.3%
16,264
-13.3%
0.56%
-27.8%
Q4 2021$9,907,00018,7640.77%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q3 2023
NameSharesValueWeighting ↓
Context Capital Management, LLC 18,764$9,907,0000.77%
Pentwater Capital Management LP 46,411,000$24,770,0000.27%
WHITEBOX ADVISORS LLC 22,500,000$11,756,0000.24%
TENOR CAPITAL MANAGEMENT Co., L.P. 20,000,000$10,993,0000.23%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 17,590,000$9,286,0000.20%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 24,000,000$12,540,0000.18%
BlueCrest Capital Management Ltd 7,000,000$3,705,0000.12%
DCF Advisers, LLC 400,000$211,0000.09%
Walleye Capital LLC 5,000$2,638,0000.08%
INGALLS & SNYDER LLC 883,000$461,0000.02%
View complete list of ESPERION THERAPEUTICS INC NE shareholders